Vaginal microbiota stability as a marker of successful outcomes of pregnancy

Abstract

Overcoming the problem of miscarriage still remains relevant today. Its' significant contribution to the structure of premature birth is due to the invasion of conditionally pathogenic microflora from the lower parts of the genital tract into the amniotic cavity. It can thus trigger an inflammatory reaction, causing early termination of pregnancy. The microbiota of the genital tract is characterized by the least diversity and high stability over time compared to any other location of the body. The dominance of certain types of lactobacilli in the vaginal biotope may be a marker of well-being, or a harbinger of termination of pregnancy. The aim of this review article is to summarize the current understanding of the vaginal microbiota during pregnancy in order to determine the relationship between its composition and stability throughout pregnancy, as well as the risk of early termination of pregnancy.

Keywords

Lactobacillus spp. / vaginal microbiota / gravidity / preterm delivery

References

[1] Gonçalves LF, Chaiworapongsa T, Romero R. Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev. 2002;8(1):3–13. DOI: 10.1002/mrdd.10008

[2] Gonçalves L.F., Chaiworapongsa T., Romero R. Intrauterine infection and prematurity // Ment. Retard. Dev. Disabil. Res. Rev. 2002. Vol. 8. No. 1. P. 3–13. DOI: 10.1002/mrdd.10008

[3] Goldenberg RL, Andrews WW, Hauth JC. Choriodecidual infection and preterm birth. Nutr Rev. 2002;60(5 Pt 2):S19–S25. DOI: 10.1301/00296640260130696

[4] Goldenberg R.L., Andrews W.W., Hauth J.C. Choriodecidual infection and preterm birth // Nutr. Rev. 2002. Vol. 60. No. 5. P. 19–25. DOI: 10.1301/00296640260130696

[5] Rossiiskoe obshchestvo akusherov-ginekologov, Assotsiatsiya akusherskikh anesteziologov-reanimatologov. Prezhdevremennye rody. Klinicheskie rekomendatsii. (In Russ.) [cited 2023 Feb 12]. Available from: https://roag-portal.ru/recommendations_obstetrics

[6] Российское общество акушеров-гинекологов, Ассоциация акушерских анестезиологов-реаниматологов. Преждевременные роды. Клинические рекомендации. 2020 [дата обращения 12.02.2023]. Доступ по ссылке: https://roag-portal.ru/recommendations_obstetrics

[7] Romero R, Gómez R, Chaiworapongsa T, et al. The role of infection in preterm labour and delivery. Paediatr Perinat Epidemiol. 2001;15(Suppl 2):41–56. DOI: 10.1046/j.1365-3016.2001.00007.x

[8] Romero R., Gómez R., Chaiworapongsa T., et al. The role of infection in preterm labor and delivery // Paediatr. Perinat. Epidemiol. 2001. Vol. 15. Suppl. 2. P. 41–56. DOI: 10.1046/j.1365-3016.2001.00007.x

[9] Steel JH, Malatos S, Kennea N, et al. Bacteria and inflammatory cells in fetal membranes do not always cause preterm labor. Pediatr Res. 2005;57(3):404–411. DOI: 10.1203/01.PDR.0000153869.96337.90

[10] Steel J.H., Malatos S., Kennea N., et al. Bacteria and inflammatory cells in fetal membranes do not always cause preterm labor // Pediatr. Res. 2005. Vol. 57. No. 3. P. 404–411. DOI: 10.1203/01.PDR.0000153869.96337.90

[11] Carey JC, Klebanoff MA, Hauth JC, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 2000;342:534–540.

[12] Carey J.C., Klebanoff M.A., Hauth J.C., et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units // N. Engl. J. Med. 2000. Vol. 342. P. 534–540. DOI: 10.1056/NEJM200002243420802

[13] Kenyon SL, Taylor DJ, Tarnow-Mordi W; ORACLE Collaborative Group. Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. ORACLE Collaborative Group. Lancet. 2001;357(9261):989–994. DOI: 10.1016/s0140-6736(00)04234-3

[14] Kenyon S.L., Taylor D.J., Tarnow-Mordi W. ORACLE Collaborative Group. Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. ORACLE Collaborative Group // Lancet. 2001. Vol. 357. No. 9261. P. 989–994. DOI: 10.1016/s0140-6736(00)04234-3

[15] Flenady V, Hawley G, Stock OM, et al. Prophylactic antibiotics for inhibiting preterm labour with intact membranes. Cochrane Database Syst Rev. 2013;(12). DOI: 10.1002/14651858.CD000246.pub2

[16] Flenady V., Hawley G., Stock O.M., et al. Prophylactic antibiotics for inhibiting preterm labor with intact membranes // Cochrane Database Syst. Rev. 2013. Vol. 12. DOI: 10.1002/14651858.CD000246.pub2

[17] Stout MJ, Zhou Y, Wylie KM, et al. Early pregnancy vaginal microbiome trends and preterm birth. Am J Obstet Gynecol. 2017;217(3):356.e1–356.e18. DOI: 10.1016/j.ajog.2017.05.030

[18] Stout M.J., Zhou Y., Wylie K.M., et al. Early pregnancy vaginal microbiome trends and preterm birth // Am. J. Obstet. Gynecol. 2017. Vol. 217. No. 3. P. 356. DOI: 10.1016/j.ajog.2017.05.030

[19] Shafquat A, Joice R, Simmons SL, et al. Functional and phylogenetic assembly of microbial communities in the human microbiome. Trends Microbiol. 2014;22(5):261–266. DOI: 10.1016/j.tim.2014.01.011

[20] Shafquat A., Joice R., Simmons S.L., et al. Functional and phylogenetic assembly of microbial communities in the human microbiome // Trends Microbiol. 2014. Vol. 22. No. 5. P. 261–266. DOI: 10.1016/j.tim.2014.01.011

[21] Bäckhed F, Fraser CM, Ringel Y, et al. Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe. 2012;12(5):611–622. DOI: 10.1016/j.chom.2012.10.012

[22] Bäckhed F., Fraser C.M., Ringel Y., et al. Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications // Cell Host Microbe. 2012. Vol. 12. No. 5. P. 611–622. DOI: 10.1016/j.chom.2012.10.012

[23] Eschenbach DA, Thwin SS, Patton DL, et al. Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora. Clin Infect Dis. 2000;30(6):901–907. DOI: 10.1086/313818

[24] Eschenbach D.A., Thwin S.S., Patton D.L., et al. Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora // Clin. Infect. Dis. 2000. Vol. 30. No. 6. P. 901–907. DOI: 10.1086/313818

[25] Li K, Bihan M, Methé BA. Analyses of the stability and core taxonomic memberships of the human microbiome. PLoS One. 2013;8(5). DOI: 10.1371/journal.pone.0063139

[26] Li K., Bihan M., Methé B.A. Analyses of the stability and core taxonomic memberships of the human microbiome // PLoS One. 2013. Vol. 8. No. 5. DOI: 10.1371/journal.pone.0063139

[27] Dethlefsen L, McFall-Ngai M, Relman DA. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature. 2007;449(7164):811–818. DOI: 10.1038/nature06245

[28] Dethlefsen L., McFall-Ngai M., Relman D.A. An ecological and evolutionary perspective on human-microbe mutualism and disease // Nature. 2007. Vol. 449. No. 7164. P. 811–818. DOI: 10.1038/nature06245

[29] White BA, Creedon DJ, Nelson KE, et al. The vaginal microbiome in health and disease. Trends Endocrinol Metab. 2011;22(10):389–393. DOI: 10.1016/j.tem.2011.06.001

[30] White B.A., Creedon D.J., Nelson K.E., et al. The vaginal microbiome in health and disease // Trends Endocrinol. Metab. 2011. Vol. 22. No. 10. P. 389–393. DOI: 10.1016/j.tem.2011.06.001

[31] Patton DL, Thwin SS, Meier A, et al. Epithelial cell layer thickness and immune cell populations in the normal human vagina at different stages of the menstrual cycle. Am J Obstet Gynecol. 2000;183(4):967–973. DOI: 10.1067/mob.[phone]

[32] Patton D.L., Thwin S.S., Meier A., et al. Epithelial cell layer thickness and immune cell populations in the normal human vagina at different stages of the menstrual cycle // Am. J. Obstet. Gynecol. 2000. Vol. 183. No. 4. P. 967–973. DOI: 10.1067/mob.[phone]

[33] Miller L, Patton DL, Meier A, et al. Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium. Obstet Gynecol. 2000;96(3):431–439. DOI: 10.1016/s0029-7844(00)00906-6

[34] Miller L., Patton D.L., Meier A., et al. Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium // Obstet. Gynecol. 2000. Vol. 96. No. 3. P. 431–439. DOI: 10.1016/s0029-7844(00)00906-6

[35] Aldunate M, Tyssen D, Johnson A, et al. Vaginal concentrations of lactic acid potently inactivate HIV. J Antimicrob Chemother. 2013;68(9):2015–2025. DOI: 10.1093/jac/dkt156

[36] Aldunate M., Tyssen D., Johnson A., et al. Vaginal concentrations of lactic acid potently inactivate HIV // J. Antimicrob. Chemother. 2013. Vol. 68. No. 9. P. 2015–2025. DOI: 10.1093/jac/dkt156

[37] Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207–214. DOI: 10.1038/nature11234

[38] Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome // Nature. 2012. Vol. 486. No. 7402. P. 207–214. DOI: 10.1038/nature11234

[39] Voroshilina ES, Plotko EE, Islamidi DK, et al. Mikrobiotsenoz vlagalishcha s tochki zreniya PTsR v real’nom vremeni. Vozmozhnosti korrektsii disbioticheskikh narushenii vlagalishcha: uchebnoe posobie. Ekaterinburg; 2018. (In Russ.) [cited 2023 Feb 12]. Available from: https://www.g-mc.ru/application/files/6015/3958/3995/mikrobiocenoz_i_ego_korrekciya_2018.pdf

[40] Ворошилина Е.С., Плотко Е.Э., Исламиди Д.К., и др Микробиоценоз влагалища с точки зрения ПЦР в реальном времени. Возможности коррекции дисбиотических нарушений влагалища: учебное пособие. Екатеринбург, 2018 [дата обращения 12.02.2023]. Доступ по ссылке: https://www.g-mc.ru/application/files/6015/3958/3995/mikrobiocenoz_i_ego_korrekciya_2018.pdf

[41] Ravel J, Gajer P, Abdo Z, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci USA. 2011;108(Suppl 1):4680–4687. DOI: 10.1073/pnas.1002611107

[42] Ravel J., Gajer P., Abdo Z., et al. Vaginal microbiome of reproductive-age women // Proc. Natl. Acad. Sci. USA. 2011. Vol. 108. Suppl. 1. P. 4680–4687. DOI: 10.1073/pnas.1002611107

[43] De Seta F, Campisciano G, Zanotta N, et al. The vaginal community state types microbiome-immune network as key factor for bacterial vaginosis and aerobic vaginitis. Front Microbiol. 2019;10. DOI: 10.3389/fmicb.2019.02451

[44] De Seta F., Campisciano G., Zanotta N., et al. The vaginal community state types microbiome-immune network as key factor for bacterial vaginosis and aerobic vaginitis // Front. Microbiol. 2019. Vol. 10. P. 2451. DOI: 10.3389/fmicb.2019.02451

[45] van de Wijgert JH, Borgdorff H, Verhelst R, et al. The vaginal microbiota: what have we learned after a decade of molecular characterization? PLoS One. 2014;9(8). DOI: 10.1371/journal.pone.0105998

[46] van de Wijgert J.H., Borgdorff H., Verhelst R., et al. The vaginal microbiota: what have we learned after a decade of molecular characterization? // PLoS One. 2014. Vol. 9. No. 8. DOI: 10.1371/journal.pone.0105998

[47] Witkin SS, Mendes-Soares H, Linhares IM, et al. Influence of vaginal bacteria and D- and L-lactic acid isomers on vaginal extracellular matrix metalloproteinase inducer: implications for protection against upper genital tract infections. mBio. 2013;4(4):e00460–e00413. DOI: 10.1128/mBio.00460-13

[48] Witkin S.S., Mendes-Soares H., Linhares I.M., et al. Influence of vaginal bacteria and D- and L-lactic acid isomers on vaginal extracellular matrix metalloproteinase inducer: implications for protection against upper genital tract infections // mBio. 2013. Vol. 4. No. 4. DOI: 10.1128/mBio.00460-13

[49] Aroutcheva A, Gariti D, Simon M, et al. Defense factors of vaginal lactobacilli. Am J Obstet Gynecol. 2001;185(2):375–379. DOI: 10.1067/mob.[phone]

[50] Aroutcheva A., Gariti D., Simon M., et al. Defense factors of vaginal lactobacilli // Am. J. Obstet. Gynecol. 2001. Vol. 185. No. 2. P. 375–379. DOI: 10.1067/mob.[phone]

[51] Sgibnev AV, Kremleva EA. Vaginal protection by H2O2-producing lactobacilli. Jundishapur J Microbiol. 2015;8(10). DOI: 10.5812/jjm.22913

[52] Sgibnev A.V., Kremleva E.A. Vaginal protection by H2O2-producing lactobacilli // Jundishapur J. Microbiol. 2015. Vol. 8. No. 10. DOI: 10.5812/jjm.22913

[53] Parolin C, Croatti V, Laghi L, et al. Lactobacillus biofilms influence anti-candida activity. Front Microbiol. 2021;12. DOI: 10.3389/fmicb.2021.750368

[54] Parolin C., Croatti V., Laghi L., et al. Lactobacillus biofilms influence anti-candida activity // Front. Microbiol. 2021. Vol. 12. DOI: 10.3389/fmicb.2021.750368

[55] Donia MS, Cimermancic P, Schulze CJ, et al. A systematic analysis of biosynthetic gene clusters in the human microbiome reveals a common family of antibiotics. Cell. 2014;158(6):1402–1414. DOI: 10.1016/j.cell.2014.08.032

[56] Donia M.S., Cimermancic P., Schulze C.J., et al. A systematic analysis of biosynthetic gene clusters in the human microbiome reveals a common family of antibiotics // Cell. 2014. Vol. 158. No. 6. P. 1402–1414. DOI: 10.1016/j.cell.2014.08.032

[57] Ma B, Forney LJ, Ravel J. Vaginal microbiome: rethinking health and disease. Annu Rev Microbiol. 2012;66:371–389. DOI: 10.1146/annurev-micro-092611-150157

[58] Ma B., Forney L.J., Ravel J. Vaginal microbiome: rethinking health and disease // Annu. Rev. Microbiol. 2012. Vol. 66. P. 371–389. DOI: 10.1146/annurev-micro-092611-150157

[59] Gajer P, Brotman RM, Bai G, et al. Temporal dynamics of the human vaginal microbiota. Sci Transl Med. 2012;4(132). DOI: 10.1126/scitranslmed.3003605

[60] Gajer P., Brotman R.M., Bai G., et al. Temporal dynamics of the human vaginal microbiota // Sci. Transl. Med. 2012. Vol. 4. No. 132. DOI: 10.1126/scitranslmed.3003605

[61] Kim H, Kim T, Kang J, et al. Is Lactobacillus gram-positive? A case study of lactobacillus iners. Microorganisms. 2020;8(7):969. DOI: 10.3390/microorganisms8070969

[62] Kim H., Kim T., Kang J., et al. Is lactobacillus gram-positive? A case study of lactobacillus iners // Microorganisms. 2020. Vol. 8. No. 7. P. 969. DOI: 10.3390/microorganisms8070969

[63] Kwak W, Han YH, Seol D, et al. Complete genome of lactobacillus iners KY using flongle provides insight into the genetic background of optimal adaption to vaginal econiche. Front Microbiol. 2020;11:1048. DOI: 10.3389/fmicb.2020.01048

[64] Kwak W., Han Y.H., Seol D., et al. Complete genome of lactobacillus iners KY using flongle provides insight into the genetic background of optimal adaption to vaginal econiche // Front. Microbiol. 2020. Vol. 11. P. 1048. DOI: 10.3389/fmicb.2020.01048

[65] Witkin SS, Linhares IM, Bongiovanni AM, et al. Unique alterations in infection-induced immune activation during pregnancy. BJOG. 2011;118(2):145–153. DOI: 10.1111/j.1471-0528.2010.02773.x

[66] Witkin S.S., Linhares I.M., Bongiovanni A.M., et al. Unique alterations in infection-induced immune activation during pregnancy // BJOG. 2011. Vol. 118. No. 2. P. 145–153. DOI: 10.1111/j.1471-0528.2010.02773.x

[67] Aagaard K, Riehle K, Ma J, et al. A metagenomic approach to characterization of the vaginal microbiome signature in pregnancy. PLoS One. 2012;7(6). DOI: 10.1371/journal.pone.0036466

[68] Aagaard K., Riehle K., Ma J., et al. A metagenomic approach to characterization of the vaginal microbiome signature in pregnancy // PLoS One. 2012. Vol. 7. No. 6. DOI: 10.1371/journal.pone.0036466

[69] Romero R, Hassan SS, Gajer P, et al. The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women. Microbiome. 2014;2(1):4. DOI: 10.1186/2049-2618-2-4

[70] Romero R., Hassan S.S., Gajer P., et al. The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women. // Microbiome. 2014. Vol. 2. No. 1. P. 4. DOI: 10.1186/2049-2618-2-4

[71] Bennett PR, Brown RG, MacIntyre DA. Vaginal microbiome in preterm rupture of membranes. Obstet Gynecol Clin North Am. 2020;47(4):503–521. DOI: 10.1016/j.ogc.2020.08.001

[72] Bennett P.R., Brown R.G., Maclntyre D.A. Vaginal microbiome in preterm rupture of membranes // Obstet. Gynecol. Clin. North. Am. 2020. Vol. 47. No. 4. P. 503–521 DOI: 10.1016/j.ogc.2020.08.001

[73] Ruhljada NN, Taits AN, Romanova LA, et al. Bacterial vaginosis as a risk factor for preterm birth. Pediatrician (St. Petersburg). 2019;10(4):97–101. DOI: 10.17816/PED10497-101

[74] Рухляда Н.Н., Тайц А.Н., Романова Л.А., и др. Бактериальный вагиноз как фактор риска преждевременных родов // Педиатр. 2019. Т. 10. № 4. C. 97–101. DOI: 10.17816/PED10497-101

[75] Dadayeva DG, Sosnina AK, Tral TG, et al. Placental inflammatory changes and their association with the vaginal microbiota before delivery. Journal of Obstetrics and Women’s Diseases. 2021;70(1):59–68. (In Russ.) DOI: 10.17816/JOWD52962

[76] Дадаева Д.Г., Соснина А.К., Траль Т.Г., и др. Воспалительные изменения в последе и их связь с микробиотой влагалища до родов // Журнал акушерства и женских болезней. 2021. Т. 70. № 1. C. 59–68. DOI: 10.17816/JOWD52962

[77] Ganu RS, Ma J, Aagaard KM. The role of microbial communities in parturition: is there evidence of association with preterm birth and perinatal morbidity and mortality? Am J Perinatol. 2013;30(8):613–624. DOI: 10.1055/s-0032-1329693

[78] Ganu R.S., Ma J., Aagaard K.M. The role of microbial communities in parturition: is there evidence of association with preterm birth and perinatal morbidity and mortality? // Am. J. Perinatol. 2013. Vol. 30. No. 8. P. 613–624. DOI: 10.1055/s-0032-1329693

[79] Kindinger LM, Bennett PR, Lee YS, et al. The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk. Microbiome. 2017;5(1):6. DOI: 10.1186/s40168-016-0223-9

[80] Kindinger L.M., Bennett P.R., Lee Y.S., et al. The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk // Microbiome. 2017. Vol. 5. No. 1. P. 6. DOI: 10.1186/s40168-016-0223-9

[81] Petricevic L, Domig KJ, Nierscher FJ, et al. Characterisation of the vaginal Lactobacillus microbiota associated with preterm delivery. Sci Rep. 2014;4:5136. DOI: 10.1038/srep05136

[82] Petricevic L., Domig K.J., Nierscher F.J., et al. Characterisation of the vaginal Lactobacillus microbiota associated with preterm delivery // Sci. Rep. 2014. Vol. 4. P. 5136. DOI: 10.1038/srep05136

[83] Sinyakova AA, Shipitsyna EV, Budilovskaya OV, et al. Anamnestic and microbiological predictors of miscarriage. Journal of Obstetrics and Women’s Diseases. 2019; 68(2):59–70. (In Russ.) DOI: 10.17816/JOWD68259-70

[84] Синякова А.А., Шипицына Е.В., Будиловская О.В., и др. Клинико-анамнестические и микробиологические предикторы невынашивания беременности // Журнал акушерства и женских болезней. 2019. Т. 68. № 2. C. 59–70. DOI: 10.17816/JOWD68259-70

[85] Vaneechoutte M. Lactobacillus iners, the unusual suspect. Res Microbiol. 2017;168(9–10):826–836. DOI: 10.1016/j.resmic.2017.09.003

[86] Vaneechoutte M. Lactobacillus iners, the unusual suspect // Res. Microbiol. 2017. Vol. 168, No. 9–10. P. 826–836. DOI: 10.1016/j.resmic.2017.09.003

[87] Hyman RW, Fukushima M, Jiang H, et al. Diversity of the vaginal microbiome correlates with preterm birth. Reprod Sci. 2014;21(1):32–40. DOI: 10.1177/1933719113488838

[88] Hyman R.W., Fukushima M., Jiang H., et al. Diversity of the vaginal microbiome correlates with preterm birth // Reprod. Sci. 2014. Vol. 21. No. 1. P. 32–40. DOI: 10.1177/1933719113488838

[89] Dunstan PK, Johnson CR. Linking richness, community variability, and invasion resistance with patch size. Ecology. 2006;87(11):2842–2850. DOI: 10.1890/0012-9658(2006)87[2842:lrcvai]2.0.co;2

[90] Dunstan P.K., Johnson C.R. Linking richness, community variability, and invasion resistance with patch size // Ecology. 2006 Vol. 87. No. 11. P. 2842–2850. DOI: 10.1890/0012-9658(2006)87[2842:lrcvai]2.0.co;2

[91] Zhang F, Zhang T, Ma Y, et al. Alteration of vaginal microbiota in patients with unexplained recurrent miscarriage. Exp Ther Med. 2019;17(5):3307–3316. DOI: 10.3892/etm.2019.7337

[92] Zhang F., Zhang T., Ma Y., et al. Alteration of vaginal microbiota in patients with unexplained recurrent miscarriage // Exp. Ther. Med. 2019. Vol. 17. No. 5. P. 3307–3316. DOI: 10.3892/etm.2019.7337

[93] DiGiulio DB, Callahan BJ, McMurdie PJ, et al. Temporal and spatial variation of the human microbiota during pregnancy. Proc Natl Acad Sci USA. 2015;112(35):11060–11065. DOI: 10.1073/pnas.1502875112

[94] DiGiulio D.B., Callahan B.J., McMurdie P.J., et al. Temporal and spatial variation of the human microbiota during pregnancy // Proc. Natl. Acad. Sci. USA. 2015. Vol. 112. No. 35. P. 11060–11065. DOI: 10.1073/pnas.1502875112

[95] Stout MJ, Zhou Y, Wylie KM, et al. Early pregnancy vaginal microbiome trends and preterm birth. Am J Obstet Gynecol. 2017;217(3):356.e1–356.e18. DOI: 10.1016/j.ajog.2017.05.030

[96] Stout M.J., Zhou Y., Wylie K.M., et al. Early pregnancy vaginal microbiome trends and preterm birth // Am. J. Obstet. Gynecol. 2017. Vol. 217. No. 3. P. 356.e1–356.e18. DOI: 10.1016/j.ajog.2017.05.030

[97] Bohbot JM, Daraï E, Bretelle F, et al. Efficacy and safety of vaginally administered lyophilized Lactobacillus crispatus IP 174178 in the prevention of bacterial vaginosis recurrence. J Gynecol Obstet Hum Reprod. 2018;47(2):81–86. DOI: 10.1016/j.jogoh.2017.11.005

[98] Bohbot J.M., Daraï E., Bretelle F., et al. Efficacy and safety of vaginally administered lyophilized Lactobacillus crispatus IP 174178 in the prevention of bacterial vaginosis recurrence // J. Gynecol. Obstet. Hum. Reprod. 2018. Vol. 47. No. 2. P. 81–86. DOI: 10.1016/j.jogoh.2017.11.005

RIGHTS & PERMISSIONS

Eсо-Vector